Arthur He

Stock Analyst at HC Wainwright & Co.

(3.28)
# 1,065
Out of 4,984 analysts
62
Total ratings
47.54%
Success rate
4.15%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Arthur He

Adagene
Aug 15, 2025
Maintains: Buy
Price Target: $8$7
Current: $2.04
Upside: +243.14%
LAVA Therapeutics
Aug 5, 2025
Maintains: Neutral
Price Target: $1.5$1.24
Current: $1.50
Upside: -17.33%
Aurinia Pharmaceuticals
Jul 30, 2025
Assumes: Buy
Price Target: $17
Current: $12.30
Upside: +38.21%
Adaptimmune Therapeutics
Jul 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.08
Upside: -
Nektar Therapeutics
Jun 24, 2025
Maintains: Buy
Price Target: $6.5$120
Current: $51.07
Upside: +134.97%
Solid Biosciences
Jun 17, 2025
Reiterates: Buy
Price Target: $20
Current: $5.47
Upside: +265.63%
Vera Therapeutics
Jun 2, 2025
Maintains: Buy
Price Target: $75$85
Current: $24.54
Upside: +246.37%
Prime Medicine
May 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.65
Upside: -
BioAtla
Mar 31, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.68
Upside: -